Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
16155 | 670 | 32.4 | 86% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
316 | 3 | RHEUMATOLOGY//RHEUMATOID ARTHRITIS//RHEUMATOL | 39766 |
3449 | 2 | INFLIXIMAB//ETANERCEPT//ADALIMUMAB | 1526 |
16155 | 1 | INFLIXIMAB//DRUG INDUCED LUPUS//ADALIMUMAB | 670 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | INFLIXIMAB | authKW | 429769 | 24% | 6% | 159 |
2 | DRUG INDUCED LUPUS | authKW | 293974 | 3% | 28% | 23 |
3 | ADALIMUMAB | authKW | 269363 | 12% | 7% | 82 |
4 | ETANERCEPT | authKW | 245692 | 13% | 6% | 86 |
5 | IMMUNOMEDIATED HEPATITIS | authKW | 136722 | 0% | 100% | 3 |
6 | TNF ALPHA ANTAGONISTS | authKW | 116499 | 2% | 17% | 15 |
7 | DRUG INDUCED LUPUS ERYTHEMATOSUS | authKW | 106330 | 1% | 33% | 7 |
8 | ADALIMUMB | authKW | 91148 | 0% | 100% | 2 |
9 | ANTI TNF ALPHA INDUCED LUPUS | authKW | 91148 | 0% | 100% | 2 |
10 | ANTI TNF ALPHA INHIBITORS | authKW | 91148 | 0% | 100% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Rheumatology | 25453 | 35% | 0% | 237 |
2 | Dermatology | 4385 | 20% | 0% | 132 |
3 | Gastroenterology & Hepatology | 1512 | 15% | 0% | 100 |
4 | Medicine, General & Internal | 95 | 7% | 0% | 48 |
5 | Immunology | 77 | 7% | 0% | 47 |
6 | Pharmacology & Pharmacy | 41 | 7% | 0% | 49 |
7 | Ophthalmology | 27 | 2% | 0% | 16 |
8 | Clinical Neurology | 25 | 4% | 0% | 29 |
9 | Allergy | 9 | 1% | 0% | 5 |
10 | Pediatrics | 7 | 2% | 0% | 15 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | UNIT INFLAMMATORY BOWEL DIS | 51267 | 0% | 38% | 3 |
2 | ADV THER EAUT ARTHRIT | 45574 | 0% | 100% | 1 |
3 | ALLERGY CLIN IMMUNOL RHEUMATOL UNIT INTERN | 45574 | 0% | 100% | 1 |
4 | AOU G MARTINO POLICLIN | 45574 | 0% | 100% | 1 |
5 | AUGENABT ST FRANZISKUS HOSP | 45574 | 0% | 100% | 1 |
6 | AUTOIMMUNE DIS JOSEP FONTSERV MALALTIES AUTO | 45574 | 0% | 100% | 1 |
7 | AUTOIMMUNE DIS JOSEP FONTSERV MALATIES AUTOI | 45574 | 0% | 100% | 1 |
8 | AUTOINFLAMMATORY DIS SECT | 45574 | 0% | 100% | 1 |
9 | BIOL PHARMACOL EVALUAT IRCCS S MAUGERI | 45574 | 0% | 100% | 1 |
10 | BISHOP AUCKLAND HOSP | 45574 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF CROHNS & COLITIS | 21927 | 3% | 2% | 22 |
2 | CLINICAL RHEUMATOLOGY | 9285 | 5% | 1% | 33 |
3 | RHEUMATOLOGY INTERNATIONAL | 7334 | 4% | 1% | 27 |
4 | JCR-JOURNAL OF CLINICAL RHEUMATOLOGY | 4419 | 2% | 1% | 12 |
5 | MODERN RHEUMATOLOGY | 3538 | 1% | 1% | 10 |
6 | FALK SYMPOSIUM | 3160 | 2% | 0% | 14 |
7 | ANNALS OF THE RHEUMATIC DISEASES | 2684 | 3% | 0% | 23 |
8 | REVISTA BRASILEIRA DE REUMATOLOGIA | 2440 | 1% | 1% | 5 |
9 | AUTOIMMUNITY REVIEWS | 2178 | 1% | 1% | 9 |
10 | JOURNAL OF DERMATOLOGICAL TREATMENT | 2162 | 1% | 1% | 8 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | INFLIXIMAB | 429769 | 24% | 6% | 159 | Search INFLIXIMAB | Search INFLIXIMAB |
2 | DRUG INDUCED LUPUS | 293974 | 3% | 28% | 23 | Search DRUG+INDUCED+LUPUS | Search DRUG+INDUCED+LUPUS |
3 | ADALIMUMAB | 269363 | 12% | 7% | 82 | Search ADALIMUMAB | Search ADALIMUMAB |
4 | ETANERCEPT | 245692 | 13% | 6% | 86 | Search ETANERCEPT | Search ETANERCEPT |
5 | IMMUNOMEDIATED HEPATITIS | 136722 | 0% | 100% | 3 | Search IMMUNOMEDIATED+HEPATITIS | Search IMMUNOMEDIATED+HEPATITIS |
6 | TNF ALPHA ANTAGONISTS | 116499 | 2% | 17% | 15 | Search TNF+ALPHA+ANTAGONISTS | Search TNF+ALPHA+ANTAGONISTS |
7 | DRUG INDUCED LUPUS ERYTHEMATOSUS | 106330 | 1% | 33% | 7 | Search DRUG+INDUCED+LUPUS+ERYTHEMATOSUS | Search DRUG+INDUCED+LUPUS+ERYTHEMATOSUS |
8 | ADALIMUMB | 91148 | 0% | 100% | 2 | Search ADALIMUMB | Search ADALIMUMB |
9 | ANTI TNF ALPHA INDUCED LUPUS | 91148 | 0% | 100% | 2 | Search ANTI+TNF+ALPHA+INDUCED+LUPUS | Search ANTI+TNF+ALPHA+INDUCED+LUPUS |
10 | ANTI TNF ALPHA INHIBITORS | 91148 | 0% | 100% | 2 | Search ANTI+TNF+ALPHA+INHIBITORS | Search ANTI+TNF+ALPHA+INHIBITORS |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SOLOMON, AJ , SPAIN, RI , KRUER, MC , BOURDETTE, D , (2011) INFLAMMATORY NEUROLOGICAL DISEASE IN PATIENTS TREATED WITH TUMOR NECROSIS FACTOR ALPHA INHIBITORS.MULTIPLE SCLEROSIS JOURNAL. VOL. 17. ISSUE 12. P. 1472 -1487 | 54 | 70% | 27 |
2 | JOYAU, C , VEYRAC, G , DIXNEUF, V , JOLLIET, P , (2012) ANTI-TUMOUR NECROSIS FACTOR ALPHA THERAPY AND INCREASED RISK OF DE NOVO PSORIASIS: IS IT REALLY A PARADOXICAL SIDE EFFECT?.CLINICAL AND EXPERIMENTAL RHEUMATOLOGY. VOL. 30. ISSUE 5. P. 700-706 | 35 | 90% | 23 |
3 | COLLAMER, AN , BATTAFARANO, DF , (2010) PSORIATIC SKIN LESIONS INDUCED BY TUMOR NECROSIS FACTOR ANTAGONIST THERAPY: CLINICAL FEATURES AND POSSIBLE IMMUNOPATHOGENESIS.SEMINARS IN ARTHRITIS AND RHEUMATISM. VOL. 40. ISSUE 3. P. 233 -240 | 38 | 64% | 84 |
4 | FAMENINI, S , WU, JJ , (2013) INFLIXIMAB-INDUCED PSORIASIS IN TREATMENT OF CROHN'S DISEASE-ASSOCIATED ANKYLOSING SPONDYLITIS: CASE REPORT AND REVIEW OF 142 CASES.JOURNAL OF DRUGS IN DERMATOLOGY. VOL. 12. ISSUE 8. P. 939-943 | 30 | 88% | 2 |
5 | HAWRYLUK, EB , LINSKEY, KR , DUNCAN, LM , NAZARIAN, RM , (2012) BROAD RANGE OF ADVERSE CUTANEOUS ERUPTIONS IN PATIENTS ON TNF-ALPHA ANTAGONISTS.JOURNAL OF CUTANEOUS PATHOLOGY. VOL. 39. ISSUE 5. P. 481 -492 | 35 | 70% | 22 |
6 | RAMOS-CASALS, M , BRITO-ZERON, P , MUNOZ, S , SORIA, N , GALIANA, D , BERTOLACCINI, L , CUADRADO, MJ , KHAMASHTA, MA , (2007) AUTOIMMUNE DISEASES INDUCED BY TNF-TARGETED THERAPIES - ANALYSIS OF 233 CASES.MEDICINE. VOL. 86. ISSUE 4. P. 242 -251 | 34 | 58% | 307 |
7 | DENADAI, R , TEIXEIRA, FV , STEINWURZ, F , ROMITI, R , SAAD-HOSSNE, R , (2013) INDUCTION OR EXACERBATION OF PSORIATIC LESIONS DURING ANTI-TNF-ALPHA THERAPY FOR INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC LITERATURE REVIEW BASED ON 222 CASES.JOURNAL OF CROHNS & COLITIS. VOL. 7. ISSUE 7. P. 517-524 | 31 | 70% | 33 |
8 | FEUERSTEIN, JD , CHEIFETZ, AS , (2014) MISCELLANEOUS ADVERSE EVENTS WITH BIOLOGIC AGENTS (EXCLUDES INFECTION AND MALIGNANCY).GASTROENTEROLOGY CLINICS OF NORTH AMERICA. VOL. 43. ISSUE 3. P. 543 -+ | 46 | 49% | 8 |
9 | CICCARELLI, F , DE MARTINIS, M , SIRUFO, MM , GINALDI, L , (2016) PSORIASIS INDUCED BY ANTI-TUMOR NECROSIS FACTOR ALPHA AGENTS: A COMPREHENSIVE REVIEW OF THE LITERATURE.ACTA DERMATOVENEROLOGICA CROATICA. VOL. 24. ISSUE 3. P. 169 -174 | 28 | 80% | 0 |
10 | COSTA, MF , SAID, NR , ZIMMERMANN, B , (2008) DRUG-INDUCED LUPUS DUE TO ANTI-TUMOR NECROSIS FACTOR ALPHA AGENTS.SEMINARS IN ARTHRITIS AND RHEUMATISM. VOL. 37. ISSUE 6. P. 381-387 | 23 | 92% | 108 |
Classes with closest relation at Level 1 |